{"entity":{"type":"insider","cik":"0001531962","url":"/insider/0001531962","json_url":"/insider/0001531962.json","name":"Nielsen Ulrik B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2012-12-04","last":"2022-01-25","span_basis":"filed_date"},"name_variants":[{"name":"Nielsen Ulrik B.","source":"filing","n_filings":13,"first_seen":"2012-12-04","last_seen":"2022-01-25"}],"transactions":[{"id":6913447,"accession":"0000899243-22-003143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-003143","line_url":"/filing/0000899243-22-003143#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14287.0,"shares_display":"14,287","price_per_share":4.2437,"price_display":"4.24","price_state":"stated","total_value":60629.7419,"total_display":"60,629.74","total_whole":"60,630","shares_owned_after":36968.0,"shares_owned_after_display":"36,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":4111286,"accession":"0001209191-17-053004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-053004","line_url":"/filing/0001209191-17-053004#line-5","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7796.0,"shares_display":"7,796","price_per_share":14.23,"price_display":"14.23","price_state":"stated","total_value":110937.08,"total_display":"110,937.08","total_whole":"110,937","shares_owned_after":22681.0,"shares_owned_after_display":"22,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-15","scope":"insider"},{"id":4111276,"accession":"0001209191-17-053004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-053004","line_url":"/filing/0001209191-17-053004#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":1420.0,"total_display":"1,420.00","total_whole":"1,420","shares_owned_after":22681.0,"shares_owned_after_display":"22,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-15","scope":"insider"},{"id":4268361,"accession":"0001209191-17-052684","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-052684","line_url":"/filing/0001209191-17-052684#line-4","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":97036.0,"total_display":"97,036.00","total_whole":"97,036","shares_owned_after":22681.0,"shares_owned_after_display":"22,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-13","scope":"insider"},{"id":4268354,"accession":"0001209191-17-052684","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-052684","line_url":"/filing/0001209191-17-052684#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14756.0,"shares_display":"14,756","price_per_share":14.46,"price_display":"14.46","price_state":"stated","total_value":213371.76,"total_display":"213,371.76","total_whole":"213,372","shares_owned_after":22681.0,"shares_owned_after_display":"22,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-11","filed_date":"2017-09-13","scope":"insider"},{"id":8208144,"accession":"0001179110-15-011404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-011404","line_url":"/filing/0001179110-15-011404#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.71,"price_display":"10.71","price_state":"stated","total_value":214200.0,"total_display":"214,200.00","total_whole":"214,200","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-20","filed_date":"2015-07-22","scope":"insider"},{"id":8453119,"accession":"0001179110-15-010110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-010110","line_url":"/filing/0001179110-15-010110#line-3","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":480800.0,"total_display":"480,800.00","total_whole":"480,800","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-19","filed_date":"2015-06-19","scope":"insider"},{"id":8478997,"accession":"0001179110-15-008112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-008112","line_url":"/filing/0001179110-15-008112#line-3","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":13.04,"price_display":"13.04","price_state":"stated","total_value":521600.0,"total_display":"521,600.00","total_whole":"521,600","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-19","filed_date":"2015-05-19","scope":"insider"},{"id":8801021,"accession":"0001179110-15-006470","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-006470","line_url":"/filing/0001179110-15-006470#line-3","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":12.88,"price_display":"12.88","price_state":"stated","total_value":515200.0,"total_display":"515,200.00","total_whole":"515,200","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-20","filed_date":"2015-04-20","scope":"insider"},{"id":8862614,"accession":"0001179110-15-005302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-005302","line_url":"/filing/0001179110-15-005302#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":11.97,"price_display":"11.97","price_state":"stated","total_value":478800.0,"total_display":"478,800.00","total_whole":"478,800","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider"},{"id":8895527,"accession":"0001179110-15-004408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-004408","line_url":"/filing/0001179110-15-004408#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":240200.0,"total_display":"240,200.00","total_whole":"240,200","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-04","filed_date":"2015-03-06","scope":"insider"},{"id":8877707,"accession":"0001179110-15-003271","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-003271","line_url":"/filing/0001179110-15-003271#line-3","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":10.91,"price_display":"10.91","price_state":"stated","total_value":218200.0,"total_display":"218,200.00","total_whole":"218,200","shares_owned_after":226811.0,"shares_owned_after_display":"226,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-23","filed_date":"2015-02-24","scope":"insider"},{"id":6608063,"accession":"0001179110-14-009386","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-14-009386","line_url":"/filing/0001179110-14-009386#line-3","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Officer (SVP and CSO)","role_mark":"O","role_mark_label":"Officer (SVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105000.0,"shares_display":"105,000","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":841050.0,"total_display":"841,050.00","total_whole":"841,050","shares_owned_after":176811.0,"shares_owned_after_display":"176,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-29","scope":"insider"},{"id":4469699,"accession":"0001179110-13-007248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-007248","line_url":"/filing/0001179110-13-007248#line-2","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Officer (SVP and CSO)","role_mark":"O","role_mark_label":"Officer (SVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10483.0,"shares_display":"10,483","price_per_share":5.396,"price_display":"5.40","price_state":"stated","total_value":56566.268,"total_display":"56,566.27","total_whole":"56,566","shares_owned_after":176811.0,"shares_owned_after_display":"176,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-24","filed_date":"2013-04-26","scope":"insider"},{"id":2379312,"accession":"0001179110-12-016846","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-12-016846","line_url":"/filing/0001179110-12-016846#line-1","is_derivative":false,"issuer_cik":"0001274792","issuer_name":"MERRIMACK PHARMACEUTICALS INC","issuer_ticker":"MACK","issuer_name_source":null,"issuer_url":"/issuer/0001274792","owner_cik":"0001531962","owner_name":"Nielsen Ulrik B.","owner_display_name":"Nielsen Ulrik B.","owner_url":"/insider/0001531962","role":"Officer (SVP and CSO)","role_mark":"O","role_mark_label":"Officer (SVP and CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":7.37,"price_display":"7.37","price_state":"stated","total_value":552750.0,"total_display":"552,750.00","total_whole":"552,750","shares_owned_after":176811.0,"shares_owned_after_display":"176,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001274792","name":"MERRIMACK PHARMACEUTICALS INC","url":"/issuer/0001274792","role":"Director, Officer (SVP and CSO)","n_filings":13,"first_seen":"2012-12-04","last_seen":"2022-01-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001531962","retrieved_at":"2026-08-24T14:18:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}